June 2019 newsletter
Therapeutic protein degradation by design Hot targets in drug discovery are constantly changing, paradigm shifts are a bit rarer. Protein ...
Tim Cheeseright, Director of Products, describes how Tversky similarity is used to perform substructure and superstructure type searches using Blaze.
Martin Slater, Director of Consulting Services, makes a case for information based strategies and ligand centric techniques which pit the efficiency of rationality against blind trial and error.
This month a small change is being made to the Spark reagent databases in that we now only include reagents that are in eMolecules’ Tiers 1, 2, and 3. These correspond to the most accessible reagents and should be a good source of inspiration for R-group design experiments in Spark.
We are delighted to announce that the keynote lecture at The Cresset User Group Meeting in 2018 will be delivered by Dr Steve Djuric, Vice President Discovery, AbbVie Inc.
Students have until January 12, 2018 to apply for a bursary to attend and present at the meeting.